Senators Wyden and Grassley launch investigation of pricing of Sovaldi, treatment for Hepatitis C Virus

Senators Wyden and Grassley have written a very tough request for documents about the pricing of Sovaldi, sent to John C. Martin, the Chair and CEO of Gilead Sciences.

The eight page letter sets out in 21 number paragraphs and countless sub-paragraphs a set requests for documents and information related to a very sweeping number of issues relating to Hepatitis C, and the pricing of Sovaldi (Gilead’s brand name for sofosbuvir).

The Grassley press release on the letter is here:
http://www.grassley.senate.gov/news/news-releases/senators-seek-details-sovaldi-pricing

The Senators letter is attached below.

Attachment
Size
James Love's Blogs Add new comment Printer-friendly version Send by email Send by email